Related Experiment Videos
The role of TNF alpha and IL-1 in rheumatoid arthritis
M Feldmann1, F M Brennan, B M Foxwell
1Kennedy Institute of Rheumatology, Hammersmith, London, UK. m.feldmann@cxwms.ac.uk
Current Directions in Autoimmunity
|January 17, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Suppression of tumour necrosis factor production from mononuclear cells by a novel synthetic compound, CLX-090717.
Rheumatology (Oxford, England)·2008
Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
Scandinavian journal of immunology·2008
Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation.
Rheumatology (Oxford, England)·2008
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
Proceedings of the National Academy of Sciences of the United States of America·2006
The importance of T cell interactions with macrophages in rheumatoid cytokine production.
Current topics in microbiology and immunology·2006
Release of tumour necrosis factor alpha (TNFalpha) by TNFalpha cleaving enzyme (TACE) in response to septic stimuli in vitro.
British journal of anaesthesia·2004
The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
Current directions in autoimmunity·2010
TNF in host resistance to tuberculosis infection.
Current directions in autoimmunity·2010
TNF-alpha and obesity.
Current directions in autoimmunity·2010
TNF and bone.
Current directions in autoimmunity·2010
TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.
Current directions in autoimmunity·2010
T cells as sources and targets of TNF: implications for immunity and autoimmunity.
Current directions in autoimmunity·2010
Phloretin Modulates STING Ubiquitination Degradation to Restrain Dendritic Cell Overactivation and Alleviate Sjögren's Syndrome.
Pharmaceuticals (Basel, Switzerland)·2026